FREEMAN KEVIN D purchased 11.1% of their position (5.50K shares) of GALECTIN THERAPEUTICS INC on the open market
Open‑market purchase worth $19.5K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/23/2025ACC: 0001133416-25-000075
+5.50K
Net shares
Net buyer
$19.5K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
5.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+5.50K
Price / share
$3.55
Trade value
$19.51K
% of position
11.1%
12/23/2025
49.77K→55.27K
Total
Net shares
+5.50K
Net value
$19.51K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/23/2025 | P · Purchase | +5.50K | $3.55 | $19.51K | 11.1% | 49.77K | 55.27K |
| Total | +5.50K | $19.51K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned80K
Common Stock
IndirectShares owned2K
Total
82K indirect82K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 80K | Indirect |
| Common Stock | 2K | Indirect |
| Total | 82K | 82K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported